1-26 of 26
Keywords: oestrogen
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Articles
Clin Sci (Lond) (2016) 130 (1): 9–18.
Published: 30 November 2015
... in the development of hypertension in both men and women is an increase in sympathetic nerve activity (SNA). Brain regions important for the regulation of SNA, such as the subfornical organ, the paraventricular nucleus and the rostral ventral lateral medulla, also express specific subtypes of oestrogen receptors...
Articles
Clin Sci (Lond) (2015) 129 (10): 885–893.
Published: 01 September 2015
..., HR correlated inversely ( P <0.05) with HF. In conclusion, ExFHA women demonstrate augmented vagal yet unchanged sympathetic HR modulation, both at rest and during orthostatic stress. Although the role of oestrogen deficiency is unclear, these findings are in contrast with studies reporting...
Articles
Clin Sci (Lond) (2013) 125 (7): 311–318.
Published: 07 June 2013
..., and postmenopausal women are at increased risk of cardiovascular complications compared with premenopausal women. The pathophysiological mechanisms have not been elucidated, but are not likely to be as simple as the presence or absence of oestrogens, since hormone replacement therapy in elderly women in the Women's...
Articles
Clin Sci (Lond) (2010) 119 (12): 493–513.
Published: 01 September 2010
... and women, the clinical impact of sex hormones on CVD, and summarize our current understanding of the pathogenesis of atherosclerosis with a focus on gender differences in CVD, its clinical presentation and course, and pathobiology. The critical animal and human data that pertain to the role of oestrogens...
Articles
Clin Sci (Lond) (2010) 118 (6): 375–389.
Published: 15 December 2009
...Hilary V.O. Carswell; I. Mhairi Macrae; Tracy D. Farr Evidence exists for the potential protective effects of circulating ovarian hormones in stroke, and oestrogen reduces brain damage in animal ischaemia models. However, a recent clinical trial indicated that HRT (hormone-replacement therapy...
Articles
Clin Sci (Lond) (2009) 117 (10): 355–364.
Published: 07 September 2009
... cells are bone-marrow-derived cells involved in endothelial healing and angiogenesis, which promote cardiovascular health. Oestrogens are potent stimulators of endothelial progenitor cells, and previous findings have indicated that androgens may improve the biology of these cells as well. In the present...
Articles
Clin Sci (Lond) (2006) 111 (2): 107–118.
Published: 13 July 2006
...Shanhong Ling; Paul Komesaroff; Krishnankutty Sudhir Although pre-menopausal women enjoy relative cardiovascular protection, hormone (oestrogen±progestin)-replacement therapy has not shown cardiovascular benefits in post-menopausal women, suggesting that the effects of oestrogens...
Articles
Articles
Articles
Clin Sci (Lond) (2002) 103 (s2002): 434S–437S.
Published: 01 September 2002
.../reperfusion increased significantly by approx. 2-fold over sham-operated rats, and this elevation was dose-dependently suppressed by the 17β-oestradiol treatment. These results suggest that oestrogen exhibits protective effects against renal dysfunction and tissue injury induced by ischaemia/reperfusion...
Articles
Articles
Clin Sci (Lond) (2001) 101 (1): 93–99.
Published: 13 June 2001
.... E. Peverill (e-mail roger.peverill@med.monash.edu.au ). 5 12 2000 5 3 2001 6 4 2001 The Biochemical Society and the Medical Research Society © 2001 2001 coagulation factor VII hormone replacement therapy oestrogen progestin 93Clinical Science (2001) 101, 93 99...
Articles
Clin Sci (Lond) (2001) 100 (5): 473–479.
Published: 29 March 2001
...Helena TEEDE; Andrea VAN DER ZYPP; Henryk MAJEWSKI Although gender and oestrogen treatment influence production of the vasorelaxant, NO, their influence on factors downstream in the NO signal-transduction pathway, specifically protein kinase G (PKG), remains unknown. We aimed to study the influence...
Articles
Articles
Clin Sci (Lond) (2001) 100 (2): 207–213.
Published: 09 January 2001
...Helena J. TEEDE; Barry P. MCGRATH; Alan TURNER; Harry MAJEWSKI The effects of combined oestrogen/progestin hormone replacement therapy (HRT) on platelet aggregation were studied using women on HRT or placebo. The study involved 32 postmenopausal women (aged 50–75 years) who were enrolled...
Articles
Clin Sci (Lond) (2000) 98 (2): 201–207.
Published: 11 January 2000
... Research Society © 2000 2000 chronic pelvic pain menstrual cycle oestrogen pelvic congestion peripheral vascular flux 201Clinical Science (2000) 98, 201 207 (Printed in Great Britain) Reproducible assessment of vaginal and rectal mucosal and skin blood flow: laser doppler fluximetry...
Articles
Clin Sci (Lond) (1999) 97 (2): 225–232.
Published: 29 June 1999
...Gishel NEW; Stephen J. DUFFY; Karen L. BERRY; Richard W. HARPER; Ian T. MEREDITH Studies have recently demonstrated that long-term oestrogen therapy improves endothelium-dependent and endothelium-independent vasodilatation in the conductance vessels of biological males. We sought to determine...
Articles
Clin Sci (Lond) (1999) 97 (1): 79–84.
Published: 01 June 1999
... isokinetic isometric oestrogen post-menopause progesterone 79Clinical Science (1999) 97, 79 84 (Printed in Great Britain) Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy Julie P. GREEVES*, Nigel T. CABLE*, Thomas...
Articles
Clin Sci (Lond) (1999) 96 (4): 357–364.
Published: 01 April 1999
... strength (maximal voluntary force; MVF), muscle cross-sectional area and bone mineral density were measured. Women entering the trial had oestrogen levels below 150 pmolċl -1 , confirming their post-menopausal hormonal status. In the treated group, MVF increased by 12.4±1.0% (mean±S.E.M.) of initial MVF...
Articles
Clin Sci (Lond) (1985) 69 (2): 235–238.
Published: 01 August 1985
...N. Mishra; C. A. Hamilton; C. R. Jones; C. Leslie; J. L. Reid 1. α 2 -Adrenoceptors on blood platelets have been widely used as a model for α-adrenoceptors in less accessible tissues. 2. The effect of oestrogen (200 μg/day intramuscularly) on α 2 -adrenoceptor number and function was studied...
Articles
Articles
Clin Sci (Lond) (1980) 58 (3): 255–257.
Published: 01 March 1980
... in the premenopausal group. 3. Oestrogen therapy reduced both serum and urinary magnesium values in oophorectomized women to premenopausal concentrations. 4. Erythrocyte magnesium concentrations were not affected by menstrual status or oestrogen therapy. 31 8 1979 31 10 1979 © 1980 The Biochemical...
Articles
Clin Sci Mol Med (1978) 54 (2): 193–195.
Published: 01 February 1978
... the skeletal response was measured by photon absorptiometry, bone mineral loss was prevented by both the oestrogen and the progestogen. 3. We confirm that mestranol significantly reduced the urinary output of hydroxyproline-containing peptide, but this did not occur during gestronol therapy, suggesting...
Articles
Clin Sci Mol Med (1975) 48 (5): 457–460.
Published: 01 May 1975
...T. Saruta; R. Nakamura; I. Saito; K. Kondo; S. Matuki 1. A large dose of oestrogen elevated the blood pressure in male Wistar rats. 2. Plasma renin substrate and renin activity increased significantly but plasma renin concentration was unchanged. 3. The increase in blood pressure induced...
Articles
Clin Sci Mol Med (1974) 47 (2): 179–187.
Published: 01 August 1974
... in the mestranol group as compared with the controls, but there was no significant difference in Na e . 5. These findings support the hypothesis that oestrogen-induced fluid retention is the result of primary water retention with secondary redistribution of body sodium. 12 3 1974 © 1974 The Biochemical...